Connection

David Cole to Recombinant Proteins

This is a "connection" page, showing publications David Cole has written about Recombinant Proteins.
Connection Strength

0.097
  1. Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix. Clin Cancer Res. 1997 Jun; 3(6):867-73.
    View in: PubMed
    Score: 0.031
  2. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
    View in: PubMed
    Score: 0.024
  3. Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2). Vaccine. 2003 Jun 02; 21(19-20):2318-28.
    View in: PubMed
    Score: 0.012
  4. Cloning, characterization and regulation of a family of phi class glutathione transferases from wheat. Plant Mol Biol. 2003 Jun; 52(3):591-603.
    View in: PubMed
    Score: 0.012
  5. Structure of a tau class glutathione S-transferase from wheat active in herbicide detoxification. Biochemistry. 2002 Jun 04; 41(22):7008-20.
    View in: PubMed
    Score: 0.011
  6. Purification, regulation and cloning of a glutathione transferase (GST) from maize resembling the auxin-inducible type-III GSTs. Plant Mol Biol. 1998 Jan; 36(1):75-87.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.